Top of page

Cheryl Chan


Advises on public and private mergers and acquisitions, investments and joint ventures, and governance and activism. One of The Deal’s 2023 “Top Women in Dealmaking.”

Cheryl advises U.S. and international clients on public and private mergers and acquisitions, investments, joint ventures, corporate governance, shareholder activism and other general corporate matters. She also represents private equity firms and their portfolio companies on a full range of transactions, including acquisitions and dispositions of investments, leveraged buyouts and minority investments.

The Deal recognized Cheryl as a “Rising Star” in 2020, and one of the “Top Women in Dealmaking” in 2021, 2022 and 2023. Cheryl was named a finalist for the American Lawyer’s “Corporate Attorney of the Year” award.

She is a Global Advisory Board Member of the Women in Law Empowerment Forum. She recently moderated a panel on “Attracting and Retaining More Women in M&A” at the 2022 “The Deal Economy: Predictions and Perspectives” conference in New York.


Experience highlights

  • Emerson on its:
    • sale of control of the Climate Technologies business in a $14 billion transaction
    • acquisition of control of Aspen Technology in an $11 billion transaction
    • $8.2 billion acquisition of National Instruments
    • $3.2 billion acquisition of the Valves & Controls business of Pentair
    • sale of its Therm-O-Disc business to One Rock Capital Partners
  • Gilead on its:
    • $21 billion acquisition of Immunomedics
    • $4.3 billion pending acquisition of CymaBay Therapeutics
    • $405 million acquisition of MiroBio
  • Brookfield Business Partners on its:
    • $13.2 billion acquisition of the Power Solutions business of Johnson Controls
    • $8.3 billion acquisition of CDK Global
    • $3.4 billion acquisition of DexKo Global
  • Owens Corning on its pending $3.9 billion acquisition of Masonite International
  • Alcoa on its pending $2.2 billion acquisition of Alumina
  • DexKo Global, a portfolio company of Brookfield, on its acquisition of the TexTrail businesses
  • Livent on its:
    • $10.6 billion merger of equals with Allkem
    • investment in Nemaska Lithium
  • Williams on its $10.5 billion acquisition of all of the outstanding public common units of Williams Partners L.P.
  • SS&C Technologies on its $5.4 billion acquisition of DST Systems
  • Spectrum Brands on the $4.3 billion sale of its Hardware & Home Improvement segment to ASSA ABLOY 
  • HP on its $3.3 billion acquisition of Poly
  • Arco Platform on its $1.5 billion going-private transaction
  • TIAA on its sale of TIAA Bank
  • Bath & Body Works (f/k/a L Brands) in the Victoria’s Secret spinoff
  • SUEZ on its $601 million sale of a minority interest in SUEZ Water Resources to PGGM
  • FTS International on its $407 million acquisition by ProFrac Holdings
  • Cboe Global Markets in its acquisition of Bids Trading
  • Pernix Therapeutics on its acquisition of assets of Orexigen Therapeutics in an auction conducted under Section 363 of the Bankruptcy Code
  • Shire on its acquisition of Foresight Biotherapeutics
  • Roche on its sale of its Florence, South Carolina manufacturing site to Patheon
  • Atairos on a series of transactions involving Learfield IMG College
  • Tailwind Capital Partners on the acquisition of AST
  • Comcast on its proposed transaction to acquire Time Warner Cable
View more experience




The Deal – “Top Women in Dealmaking,” M&A, 2021, 2022 and 2023

The Deal – “Top Rising Stars: Class of 2021”

The Deal“Rising Star,” 2020

American Lawyer - “Corporate Attorney of the Year” finalist, 2022

J.D., Harvard Law School
  • cum laude
A.B., Government, Harvard University
  • summa cum laude
  • Phi Beta Kappa
Professional history
  • Partner, 2020-present
  • Davis Polk since 2012
Qualifications and admissions
  • State of New York
Back to top